BioSyent Inc. Announces Q3 Results: Sales Up 153% for the Qtr, 90% for 9 Months; Ytd Net Income $ 296,491
15th Nov 2006, 03:53 GMT
BioSyent Inc. ("BioSyent")(TSX VENTURE: RX) today released its third quarter 2006 financial results. Sales for the quarter ended September 30, 2006 were $627,244 up 153% compared to the same...
BioSyent Inc. Announces Q3 Results: Sales Up 153% for the Qtr, 90% for 9 Months; Ytd Net Income $ 296,491 related news:
- BioSyent Inc.: BioSyent Inc. Announces Q3 Results: Sales Up 153% for the Qtr, 90% for 9 Months; Ytd Net Income $ 296,491 — Market Wire - Medical and Healthcare
- Human Pheromone Sciences Announces Q3 Results — StratWire - Business of Healthcare NewsFeed
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Symbollon Pharmaceuticals, Inc.: Symbollon Pharmaceuticals Announces Third Quarter 2006 Results — Market Wire - Pharmaceuticals and Biotech
- EXX INC Announces Third Quarter Consolidated Sales and Net Income for 2006 — Automotive Headlines
- Perceptron, Inc.: Perceptron Announces First Quarter Results for Fiscal Year 2007 and Receipt of First Order for Commercial Products — Market Wire - Automotive
- Max Re Posts $26.5 Million Q3 Net Income; Names Becker Chairman, CEO — Insurance Journal
- Wilmington Capital Management Inc.: Wilmington Announces 2006 Third Quarter Results — Market Wire - Agriculture
- Orion HealthCorp Announces Q3 Results — StratWire - Business of Healthcare NewsFeed
- DAC Technologies Group International, Inc.: DAC Technologies Announces Quarterly Results for Period Ending September 30, 2006 — Market Wire - Manufacturing and Production
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL